Literature DB >> 28524055

Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients.

Giusy Fatigato1, Silvano Capitani2, Daniela Milani3, Silvia Grassilli3, Ayman Am Alameen3, Marco Candiani4, Carlo Riberti4, Marco Galasso2, Maurizio Previati2.   

Abstract

Of skin cancers, 9% arise at the periocular level, constituting a significant threat due to the proximity to intracranial structures, such as the eyes, nerve endings and proximal tissues. Tumour recurrence can be frequent and represents a primary clinical challenge for the surgeon. To present a retrospective study on the treatment of eyelid tumours at a tertiary care centre in Italy over an eight-year period and, in particular, to underline the risk factors associated with tumour relapse. Among a cohort of 205 patients, a retrospective study was conducted on 142 basal cell carcinoma (BCC) patients with eyelid tumours treated with surgical excision. Relapse-free survival was assessed using univariate Kaplan-Meier and multivariate Cox regression analysis. Over an eight-year study period, we detected 23 cases of BCC recurrence, with tumour localization associating with tumour relapse, representing an independent risk factor. The extent of the area of excision was significantly associated with relapse, but not margin positivity which was associated with reduced relapse-free survival. To minimize relapse of basal cell carcinoma during patient management, relevant factors to consider before and after tumour excision include tumour localization, margin invasion, and extension of the excision, but not the surgical technique used.

Entities:  

Keywords:  basal cell carcinoma; eyelid; reconstructive surgery; skin cancer

Mesh:

Year:  2017        PMID: 28524055     DOI: 10.1684/ejd.2017.3026

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  1 in total

1.  Characteristics and Recurrence of Primary Eyelid Basal Cell Carcinoma in Central Spain.

Authors:  Alicia Galindo-Ferreiro; Hortensia Sanchez-Tocino; Cecilia Diez-Montero; Minal Belani-Raju; Raquel García-Sanz; Miguel Diego-Alonso; Ines Llorente-Gonzalez; Patricia Callejo Perez; Rajiv Khandekar; Silvana Schellini
Journal:  J Curr Ophthalmol       Date:  2020-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.